E. coli Antibiotic Resistance 1

E. COLI ANTIBIOTIC RESISTANCE

Escherichia coli and Antibiotic Resistance to Tetracycline Antibiotics

Taylor Dodgen

A Senior Thesis submitted in partial fulfillment
of the requirements for graduation
in the Honors Program
Liberty University
Spring 2008

E. coli Antibiotic Resistance 2

Acceptance of Senior Honors Thesis
This Senior Honors Thesis is accepted in partial
fulfillment of the requirements for graduation from the
Honors Program of Liberty University.

______________________________
Randall Hubbard Ph.D.
Chair of Thesis

______________________________
Marcus Ross Ph.D.
Committee Member

______________________________
Mark Hamilton Ph.D.
Committee Member

______________________________
Marilyn Gadomski, Ph.D.
Assistant Honors Director

______________________________
Date

E. coli Antibiotic Resistance 3
Abstract
Escherichia coli cells growing under ideal conditions are able to complete one
reproduction cycle in as little as every twenty minutes. Since so many generations are
able to be observed, one should theoretically be able to observe thousands of generations
and determine evolution’s effects over a short period of time. In this experiment, E. coli
K12 cells were cultured under ideal growth conditions but in the presence of antibiotics
as a selective environmental stress in order to select for resistance. This was
accomplished by serially passing colonies that were in close contact with two different,
but similar antibiotics over a period of more than 4,000 generations. The goal was to
improve research in the antibiotic sensitivity properties of E. coli and to determine if the
data are in agreement with the theory that bacteria or other species will accumulate new
phenotypic traits via development of genotypic changes that will enhance the survival of
the organism, especially under selective pressure (e.g. growth with the presence of an
antibiotic). The diameter of E. coli colonies’ zones of inhibition decreased over time in
response to the antibiotics Doxycycline and Tetracycline indicating decreased sensitivity
to these antibiotics. The cultures, however, appeared to have increased fitness cost as
compared to the wild type.
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Escherichia coli and Antibiotic Resistance to Tetracycline Antibiotics
Bacterial antibiotic resistance
The phenomenon of bacterial drug resistance was first documented in 1951 (1).
Interest in bacterial antibiotic resistance continues to increase as some antibiotics are less
effective against pathogens and as deaths from bacterial infections that do not respond to
common antibiotic therapy are increasing. This problem is an area of interest in the
scientific community for two reasons. First, those working in medical fields are
concerned because human lives are at stake. Second, this issue is of importance to
evolutionists because they believe that the mutations in bacteria responsible for some
instances of drug resistance when faced with antibiotic therapy are favorable from the
standpoint of the bacterial population, and thus offers real-time evidence for evolution.
The argument is that the bacteria have adapted (so they can live to fight another day)—an
example of an advantageous mutation (1). Evolutionist Colin Patterson commented that
“the development of antibiotic-resistant strains of bacteria, and also of insects resistant to
DDT and a host of other recently discovered insecticides are genuine evolutionary
changes” (2). Bacterial antibiotic resistance is one of the most cited modern examples of
evolution. It seems to fit the model so well that proponents of evolution use it as the
primary example of beneficial mutations.
Mechanisms of Antibiotic Inhibition of Bacteria
Tetracycline (Tet) was first isolated in 1945 (3) and has been used extensively
since the 1950’s. Many bacterial pathogens have developed or acquired resistance to Tet
(4). Tet inhibits the binding of aminoacyl-tRNA’s to the A site of the 30S ribosomal
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subunit, which inhibits protein synthesis (4, 5). There is a primary Tet binding site and up
to 5 secondary Tet binding sites on the ribosome (6, 7).
Most cases of Tet resistance are due to resistance genes that either encode energydependent pumps to transport Tet outside of the bacteria, or make a ribosomal protection
protein, which displaces Tet from the bacterial ribosome (4, 5). These resistance genes
are passed as plasmids, integrons, and transposons, (4) and the passing of these genes
among E. coli populations was discovered in 1960 (8). Clinical resistance to multiple
antibiotics due to mutations alone, which is the focus of this study, has also been
documented due to over-expression of existing chromosomal genes (9, 10). Resistance to
Tet due to a mutation in the 16S rRNA of Propionibacterium acnes that interfered with
the Tet binding site was documented in 1998 (11). Since then, 16S rRNA mutation sites
that lead to Tet resistance in Helicobacter pylori have been well documented (12, 13, 14,
and 15). Tet resistance in Escherichia coli genetically structured for point mutations at
positions 965-967 and independently at 1058 in the rRNA (resulting in a single
nucleotide change) have also been recently documented (16).
Doxycycline (Dox) is an analog of tetracycline and belongs to the same family of
antibiotics. It was semisynthetically derived from Tet and exhibits more favorable
pharmokinetic properties than early tetracyclines (17).
E. coli and Antibiotic Resistance
E. coli were first discovered in 1885 by Theodore Escherich, a German
pediatrician and bacteriologist. It is one of many species of bacteria living in the lower
intestines of mammals, known as normal gut flora, and when located in the large
intestine, E. coli assists with food absorption, waste processing, and vitamin K
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production. However, there are pathogenic strains, and it is one of the most frequently
isolated bacterial pathogens (18).
On average, E. coli cells living in a Petri dish with plenty of nutrients and
incubated at the right temperature (thus keeping it in the log phase of growth) are able to
duplicate their chromosomal DNA and split into two new cells every 20 minutes. One
should be able to see the effects of evolution on an experimental time scale due to the
rapid generation time if evolutionary change can occur over several thousand generations
as in this study.
Scientists know more about E. coli than any other bacteria in the world. E. coli is
useful as a research tool because so much is already known about its systems and
biochemistry (19). Its entire genome has been sequenced (20), so finding any genetic
aberrations and determining their effect in the phenotype is much easier than in other,
unsequenced genotypes. However, it can still be difficult to determine the genetic causes
for morphological or phenotypic changes (21). E. coli is a useful research tool, and
microbiologists have extensively studied this species of bacteria in their attempts to
understand antibiotic resistance.
E. coli and evolution
Speaking about E. coli in an evolutionary context, zoologist Pierre-Paul Grassé
observed:
...bacteria, despite their great production of intraspecific varieties, exhibit
a great fidelity to their species. The bacillus Escherichia coli, whose
mutants have been studied very carefully, are the best example. The reader
will agree that it is surprising, to say the least, to want to prove evolution
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and to discover its mechanisms and then to choose as a material for this
study a being which practically stabilized a billion years ago (1).
Although E. coli has allegedly undergone billions of year’s worth of life history, it
still has remained stable as an organism and essentially unchanged. The bacterial
population has incurred some changes due to mutations and DNA transpositions, but
these changes have occurred within narrow limits. Thus, the goal of this study is to add to
the research in antibiotic sensitivity and resistance of E. coli and to determine whether or
not the data agrees with the theory of evolution and the theory that antibiotic resistance
will occur in the face of constant exposure to a low level of antibiotics, as it would be
when subjected to antibiotic therapy in an infected patient.
Experimental Procedures
Preparation of E. coli Cultures
The experiment was designed to only test for antibiotic sensitivity due to random
mutations. In order to do this, a defined culture was used and kept isolated from any other
form of live or dead bacteria, from which it would be possible to gain antibiotic
resistance through horizontal gene transfer (as in a plasmid).
An E. coli K12 culture was streaked for isolation on trypticase soy agar (TSA)
(Becton, Dickson and Co.) for isolation. This step was to ensure the continuous purity of
E. coli. Pure E. coli colonies were found in and passed from the fourth quadrant of the
streak plate after one-day incubation at 37oC. A gram stain was performed to confirm the
microbe’s identity and its purity. The E. coli was then transferred into trypticase soy
broth (TSB) (Becton, Dickson and Co.), and grown for 24 hours at 37oC. This E. coli
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culture was used as the beginning stock culture for this experiment. All steps were
performed using aseptic technique.
Testing for antibiotic sensitivity
The Kirby-Bauer (KB), or disk diffusion antibiotic sensitivity test, was the
antibiotic sensitivity test used in this experiment (22). In this test, spread plates are
prepared on Mueller Hinton II Agar plates (MHA II) (Becton, Dickson and Co.) using 0.1
mL of the broth culture, then wafers (filter paper discs) that are impregnated with the
desired antibiotic concentration are placed on the spread plate. The antibiotic diffuses out
from the disk into the agar in a gradient, so the agar closest to the disk has the highest
concentration, and the concentration of the antibiotic decreases as you move further away
from the disk.
The broth cultures of E. coli were grown until they had an optical density (OD)
(or absorbance) of 0.8 – 1.0 at 600 nm wavelength. A KB test was performed in order to
test for the best antibiotics to be used. The twelve different antibiotics tested were
Tetracycline, Doxycyline, Thymol, Penicillin, Ampicillin, Bacitracin, Ciprofloxacin,
Cephalosporin, Chloramphenicol, Vancomycin, Streptomycin, and Erythromycin. The
organism was sensitive to Tetracycline, Doxycycline, Ciprofloxacin, Cephalosporin,
Chloramphenicol, Streptomycin, and Erythromycin. Tetracycline and Doxycycline were
chosen as the antibiotics to be used in this experiment because the organism was sensitive
to both and both antibiotics have a similar mechanism of action.
Antibiotic Sensitivity Testing Successive E. coli Generations
Because the colonies nearest to the zones of inhibition of Tet and Dox (those
exposed to the highest antibiotic concentration) may have the highest potential for
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developing antibiotic resistance (high potential colonies), colonies from the margin of the
zones of inhibition were inoculated in two different TSB’s, one from the Tet zone and
one from the Dox zone, for one day at 37oC. Note: The original cultures of Tet and Dox,
which were derived from organisms growing at the margin of the zone of inhibition for
the individual antibiotic, were propagated separately, but each was tested for sensitivity
to both Tet and Dox at each serial pass. No antibiotics were administered to any of the
broth cultures, which were used solely to generate enough bacteria to repeat the KirbyBauer test with organisms taken from the margin of the zones of inhibition.
The pair of inoculated broths of E. coli were grown to an optical density within
the range of 0.62 to 1.0 at 600 nm (after the sixth passage, some cultures were unable to
grow to an OD between 0.8 and 1.0, which was the initial OD target zone) which was
considered acceptable. 0.1 ml from each E. coli broth was transferred and spread onto
two separate MHA II plates in order to measure the new zones of inhibition for both
antibiotics. On each plate the diameter of the zones of inhibition for each antibiotic were
measured. For example, colonies for one culture of E. coli were only taken from the edge
of the Tet zone of inhibition, but sensitivity to both antibiotics was always measured. The
same procedure was used for the other culture as well. This process was repeated 12
times from inoculating colonies from the margin of the zones of inhibition to measuring
the zones of inhibitions. All broths and MHA II plates were labeled including date, name
of antibiotic, and the optical density at 600 nm wavelengths. All the steps were done
using aseptic technique.
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Results
Initial antibiotic sensitivity
The results for the initial antibiotic sensitivity test against twelve antibiotics are
shown in figure 1. Tet and Dox were chosen for further studies based on the similarity in
mechanism of action and comparable zones of inhibition.
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Figure 1 Zones of Inhibition for 12 Antibiotics

The initial zones of inhibition in mm of E. coli K12 for twelve antibiotics using the KB
method of antibiotic sensitivity testing after 24 hour incubation at 37° C. All zone of
inhibition measurements were performed on MHA II.
Optical Densities
The optical density of the broths was tracked to keep it as constant as possible
throughout the experiment so that approximately the same number of bacteria (107 to 108)
was plated each time a spread plate was performed. As shown in figure 2, the optical
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density did have some variance. Note: As the experiment progressed, the time required
for the broth cultures to grow to an optical density between 0.62 and 1.0 took an
increasing amount of time as reported in figure 3. After the sixth passage (at day 22),
some of the samples did not reach the initial OD target zone of 0.8 to 1.0 at 600 nm. The
sample numbers in the figure 2 and 3 correspond to days as shown in table 1.
OD of Broths at 600 nm vs. Sample Number
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Figure 2. OD of Broths at 600 nm vs. Sample Number

The optical densities of both the Dox (blue) and Tet (pink) broth cultures over time.
Sample 6 (at day 22) was the first broth culture not able to reach an OD of 0.8 at 600 nm.
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Days to reach OD vs. Sample number
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Figure 3. Days to Reach OD vs. Sample Number

The days allowed for the E. coli broth cultures to grow to an OD between 0.62 and 1.0 at
600 nm. Sample 6 was the first culture that did not grow to an OD of more than 0.8 at
600 nm.
Table 1.
Sample Number and Days to Reach OD
The correlation between the sample number and the number of days passed.
Sample
Number
1
2
3
4
5
6
7
8
9
10
11

Days
7
10
14
17
20
22
24
30
35
41
59
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Change in Antibiotic Sensitivity
The zones of inhibition for the doxycyline plates were tracked for the entire
experiment. Figure 4 shows the antibiotic sensitivity against both tetracycline and
doxycyline that developed over time for the doxycycline cultures. This reflects data from
the bacteria passed from the margin of the zone of inhibition to doxycycline and then
tested for sensitivity to both doxycycline and tetracycline. Table 2 shows the zones of
inhibition for the antibiotic sensitivity tests to Dox and Tet in mm.
Dox Plate- Dox and Tet ZI vs. Days

Zones of Inhibition (mm)
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Figure 4. Dox Plate-Dox and Tet Plate ZI vs. Days

The diameters of the zones of inhibition in mm for cultures tested for Tet (Dox plate-Tet)
in pink and Dox (Dox plate-Dox) in blue sensitivities on the plates propagated from
organisms from the margin of the zone of inhibition of Dox. This graphically represents
the sensitivity to Tet and Dox for the bacteria selected from the margins of the zone of
inhibition to Dox.
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Table 2.
Dox Culture Days with corresponding Dox and Tet ZI’s
The diameter of the zones of inhibition in mm for both Dox and Tet from the culture
propagated from colonies near the margin of the Dox antibiotic disk.

Days
0
7
10
14
17
20
22
24
30
35
41
59
64

Dox Culture
Dox ZI
Tet ZI
20
21
18
20
17
21
17
21
16
19
15
18
13
16
11.5
15
13
16
13
16
12
14
13
17
13
13

The zones of inhibition for the tetracycline plate were also tracked for the entire
experiment. Figure 5 shows the sensitivity to both Tet and Dox that changed over time on
the Tet plates. Table 3 shows the diameters of the zones of inhibition for the antibiotic
sensitivity tests to Tet in mm.

E. coli Antibiotic Resistance 15

Tet Plate- Dox and Tet ZI vs. Days
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Figure 5. Tet Plate-Dox and Tet ZI vs. Days

The diameters of the zones of inhibition for cultures tested for Tet sensitivity (Tet plateTet) in pink, and Dox sensitivity (Tet plate-Dox) in blue, on the plates derived from high
potential colonies for decreased Tet sensitivity over time. This graphically represents the
sensitivity to Tet and Dox for the bacteria selected from the margins of the zone of
inhibition to Tet.
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Table 3.
Tet Culture Days with corresponding Dox and Tet ZI’s
The diameters of the zones of inhibition for both Dox and Tet from the culture
propagated from colonies near the margin of the Tet antibiotic disk.

Days
0
7
10
14
17
20
22
24
30
35
41
59
64

Tet Culture
Dox ZI
Tet ZI
20
21
17
21
17
21
18
20
16
18
21
17
16
17
15
16
15
18
14
16
13
14
14
15
12
13

Figure 6 compares the diameters of the zones of inhibition to Dox for the culture
that was propagated in the presence of Dox (Dox plate-Dox) with the diameters of the
zones of inhibition for Tet for the culture that was propagated in the presence of Tet (Tet
plate-Tet).
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ZI of Tet plate-tet & Dox plate-Dox vs. Days

Zones of inhibition (mm)
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Figure 6. ZI of Tet Plate-Tet and Dox Plate-Dox vs. Days

The diameters of the zones of inhibition in mm for the cultures tested for sensitivity to
Tet and Dox for the plates derived from high potential colonies for decreased Tet (Tet
plate-Tet) and Dox (Dox plate-Dox) sensitivity over time. This graphically represents the
sensitivity to Dox for the bacteria propagated in the presence of Dox and the sensitivity to
Tet for the bacteria propagated in the presence of Tet.
Figure 7 compares the diameters of the zones of inhibition to Dox for the culture
that was propagated in the presence of Tet (Tet plate-Dox) with the diameters of the
zones of inhibition for Tet for the culture that was propagated in the presence of Dox
(Dox plate-Tet).
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ZI of Tet plate-Dox & Dox plate-Tet vs. Days
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Figure 7. ZI of Tet Plate-Dox and Dox Plate-Tet vs. Days

The diameters of the zones of inhibition in mm for the cultures tested for sensitivity to
Tet and Dox for the plates derived from high potential colonies for decreased Tet (Tet
plate-Dox) and Dox (Dox plate-Tet) sensitivity over time. This graphically represents the
sensitivity to Dox for the bacteria propagated in the presence of Tet and the sensitivity to
Tet for the bacteria propagated in the presence of Dox.
Figure 8 compares the diameters of the zones of inhibition to Dox for the culture
that was propagated in the presence of Tet (Tet plate-Dox) with the diameters of the
zones of inhibition for Dox for the culture that was propagated in the presence of Dox
(Dox plate-Dox) as well as the average of the two zones of inhibition. This shows the
antibiotic sensitivity a single antibiotic that arose by two separate means (one by
culturing with Dox, and the other with Tet).
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Dox Plate-Dox, Tet Plate-Dox, and Avg. Dox ZI vs. Days
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Figure 8. Dox Plate-Dox, Tet Plate-Dox, and Average Dox ZI vs. Days

The diameters of the zones of inhibition in mm for the cultures tested for sensitivity to
Dox for the plates derived from high potential colonies for decreased Dox (Dox plateDox) and Tet (Tet plate-Dox) sensitivity over time as well as the average between the
two. This graphically represents the sensitivity to Dox for the bacteria propagated in the
presence of Dox and Tet as well as the average of the two. This shows the change in
antibiotic sensitivity to a single antibiotic (Dox) derived by two separate means (one by
culturing with Dox, and the other with Tet).
Figure 9 compares the diameters of the zones of inhibition to Tet for the culture
that was propagated in the presence of Tet (Tet plate-Tet) with the diameters of the zones
of inhibition for Tet for the culture that was propagated in the presence of Dox (Dox
plate-Tet) as well as the average of the two zones of inhibition. This shows the antibiotic
sensitivity a single antibiotic that arose by two separate means (one by culturing with
Dox, and the other with Tet).
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Tet Plate-Tet, Dox Plate-Tet, and Avg. Tet ZI vs. Days

Zones of Inhibition (mm)
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Figure 9. Tet Plate-Tet, Dox Plate-Tet, and Average Tet ZI vs. Days

The diameters of the zones of inhibition in mm for the cultures tested for sensitivity to
Tet for the plates derived from high potential colonies for decreased Tet (Tet-Plate Tet)
and Dox (Dox Plate-Tet) sensitivity over time as well as the average between the two.
This graphically represents the sensitivity to Tet for the bacteria propagated in the
presence of Dox and Tet as well as the average of the two. This shows the change in
antibiotic sensitivity to a single antibiotic (Tet) derived by two separate means (one by
culturing with Dox, and the other with Tet).
Optical Density Related to Zones of Inhibition
As a control, the zones of inhibition for the plates prepared from the Dox broths
were compared to their corresponding optical densities which produced figure 10. Figure
10 compares the data points and linear trends for the Dox broths vs. the diameters of the
zones of inhibition for both Tet and Dox.
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Dox OD vs. resulting Dox and Tet ZI
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Figure 10. Dox OD vs. resulting Dox and Tet ZI

The linear trends of the optical densities for the culture incubated in the presence of Dox
vs. the diameters of the zones of inhibition around both the Tet (Dox plate-Tet) and Dox
(Dox plate-Dox) antibiotic discs.
The zones of inhibition for the plates prepared from the Tet broths were also
compared to the corresponding optical densities which produced figure 11. Figure 11
depicts the data points for the Tet broth optical densities vs. the zones of inhibition for
both Tet and Dox.
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Tet OD vs. resulting Dox and Tet ZI
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Figure 11. Tet OD vs. resulting Dox and Tet ZI

The linear trends of the optical densities for the culture incubated in the presence of
tetracycline and the resulting diameters of the zones of inhibition around both the Tet
(Tet plate-Tet) and Dox (Tet plate-Dox) antibiotic discs.
Over time, the growth of the E. coli in the broths considerably slowed. After the
sixth passage, some of the broths were not even able to grow above an absorbance of 0.8
at 600nm.
Discussion
Zones of Inhibition
E. coli cultures were incubated for a total of 64 days. Our objective was to keep
colonies in the log phase of growth, which would result in 72 reproduction cycles per
day, or 4,608 total divisions. In this amount of time, our E. coli showed a decrease in the
diameter of the zone of inhibition and therefore a decrease in the sensitivity to these
antibiotics.
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Our results show that E. coli has the capacity to have a decrease in antibiotic
sensitivity over time, but whether or not it can become completely resistant to either
antibiotic due to random mutations alone is inconclusive from our data (figures 4-9).
Optical Densities
As noted above, the bacteria in the broths after the sixth passage appeared to be
less fit than they were at the beginning of the experiment and were unable to reach optical
density of more than 0.8 at 600nm. The author believes that while these cells are less
sensitive to the antibiotics (as observed by the diameters of the zones of inhibition) when
in the presence of Dox or Tet (as on the MHA II plates), they are probably less competent
than wild type E. coli (i.e. less metabolically able to support rapid growth), which could
reach optical densities of 8.0 – 1.0 in one to two days.
Optical Density Related to Zones of Inhibition
There appears to be a strong correlation between the OD that the broths were able
to reach and the zones of inhibition that were produced from them (Figures 10 and 11).
The lower OD’s correspond to smaller zones of inhibition. The data seem to suggest that
the less sensitive cultures are not able to grow as quickly as the wild type cultures, or at
least not able to grow to higher OD’s (above 0.8 at 600 nm).
Fitness Cost
Ribosomes are the translational centers of the cell. The tetracycline group of
antibiotics inhibits the ribosomes of bacteria by binding the 30S rRNA and blocking the
binding of aminoacyl-tRNA’s to the A site and therefore slow or stop the production of
proteins. It logically follows that if the E. coli have acquired mutations in their ribosomes
that decrease the efficacy of the antibiotics (i.e. change the ribosome in some way), that it
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could be possible to see a decrease in their growth rate, due to less efficient translation
and production of needed proteins.
For example, the streptomycin resistance mutation of E. coli (rpsL) is due to a
mutation in the ribosome which makes the bacterium resistant to streptomycin, but with
overall translational fitness costs to the bacteria (23, 24). In the presence of streptomycin,
these E. coli are more fit (they survive streptomycin treatment), but if removed from the
streptomycin environment, they are less fit than wild type cells (do not reproduce as
well).
Increased fitness costs have been documented for pathogenic strains of E. coli that
gain resistance to quinolones (25, 26) as determined by the decrease in the number of
virulence factors the resistant E. coli strains possess. Although some studies have shown
that it is possible for wild type E. coli cultures to acquire spontaneous antibiotic
resistance to fluoroquinolones without the loss of any virulence factors (27), these
antibiotics have a different mechanism of action than tetracycline antibiotics. They
disrupt DNA gyrase and topoisomerases, instead of ribosomes.
In 2007, the first fitness evaluation was performed on Tet resistant strains of E
coli. by Erjavec et al. They performed fitness tests on 110 Tet resistant E. coli isolates
and determined that there was a statistically significant decrease in the virulence potential
of the Tet resistant strains of E. coli (28).
The zones of inhibition of our E. coli seem to have leveled off around 13 mm for
both the Dox and Tet cultures (figures 4-9). This could be coincidence, but the author
believes that further mutations are too detrimental for the cells in order to be viable.
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Studies have shown that fitness costs for mutations in the ribosome that lead to antibiotic
resistance tend to be high (23, 24).
Evolution of E. coli
In the case of sexual organisms (such as humans), a species is a group of
organisms who can breed amongst themselves, but not with another species. In the case
of bacteria (which are asexual), species are defined based on their phenotypic similarity,
genetic makeup, and biochemical traits (36). In E. coli, the cultures have to be
morphologically similar and over 70% of their DNA has to reassociate under moderately
restrictive condition (36) in order to be considered of the same species. Our E. coli
organisms did not evolve into a new species over a period of 4,600 generations. Under
intense artificial selection adaptation was observed (as evidenced by the decrease in the
diameter of the zones of inhibition), however, no new traits were observed, so no
evidence of macroevolution was observed.
Evolution of E. coli vs. evolution of man
One could argue that macroevolution is just the sum total of all the adaptation and
microevolution that occurs. While this may be true, it would be beneficial to ask why we
are not able to observe this effect even among organisms whose generational periods
extend even beyond ours. In a study done by Tim Cooper, Daniel Rosen, and Richard
Lenski, 12 lines of E. coli cells were propagated for 20,000 generations in glucoselimited media to determine what mutations they would develop separately from each
other but under the same selective stress (21). In this study, the bacteria did have some
changes, but they were still E. coli after 20,000 generations. If one was to translate
20,000 generations to a human evolutionary time scale, given a 15-20 year generational
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time, this translates to 300,000 to 400,000 years. One would expect an organism under
intense selective pressure to be able to evolve into a more fit organism in this amount of
time if evolutionary change is possible in several thousand generations.
According to human evolutionary theory, Homo sapiens evolved approximately
250,000 years ago and the next most recent species lived as little as 12,000 years ago (H.
floresiensis). Since the evolution of H. sapiens about 250,000 years ago, there have been
at least 3 other contemporaneous species (H. heidelbergensis, H. rhesiensis, and H.
neanderthalensis) that have come and gone (37). The number of years ago that an
organism lived is much less relevant in the study of evolution than the number of
generations. This is because evolution is supposed to take place through random
mutations that are passed on to the next generation. Homo sapiens are estimated to have
evolved about 250,000 years ago from Homo erectus. This change is said to have started
to occur when the cranial capacity began increasing somewhere around 400,000 years
ago (37). This would mean that the evolution from H. erectus to H. sapiens could take
place in about 150,000 years. If the average generation time was 15-20 years, this gives
only 7,500-10,000 generations for the new species to evolve. Over the course of 4,600
generations, our E. coli cells have only managed to minimally decrease their zones of
inhibition and definitely have not evolved into a new species.
Macroevolution vs. Microevolution
The term microevolution was first coined by Russian entomologist Iuri’i
Filipchenko in 1927 while trying to reconcile evolution with Mendelian genetics (31).
Microevolution describes evolution that occurs below the species level, and can result in
subspecies. Macroevolution describes evolutionary change at or above the species level.
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These terms should not be confused. Microevolution has been scientifically
proven, and is not under scrutiny. This phenomenon is due to a number of factors,
including “natural selection, gene flow, random genetic drift, and mutation.” (32). This is
made possible in part by sexual organisms with heterozygous genotypes in the
population. When organisms with heterozygous genotypes mate, some of the offspring
display the recessive phenotypes while the rest display the dominant phenotypes. When
environmental pressures change, some of these recessive phenotypes may be more fit
than other phenotypes to survive and reproduce. The net result in the population can be a
shift in the phenotype to recessive traits. A well-known example of this includes
Darwin’s finches. They were all still finches, but they had several differences, such as
beak characteristics, behaviors, and song melodies (34). Through microevolution,
subspecies can form (as in dogs) but they have not been shown to evolve into an entirely
new species.
The problem with calling bacterial antibiotic resistance a “genuine example of
evolutionary change,” (2) is that it doesn’t qualify as macroevolution. Usually, the genes
for antibiotic resistance are already in the population of bacteria whose genomes are at
least as diverse as eukaryotic organisms (29). As plasmids get passed from one bacterium
to another, the genes for antibiotic resistance become more prevalent within populations
(30). In vitro mating of Tet sensitive strains of E. coli to Tet resistant strains, and in vivo
tests in mice and chickens, have shown that Tet resistance genes are transferrable in both
circumstances (30). This can look similar to macroevolution, but before antibiotics were
even discovered, these genes were present in the population. For example, only four years
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after penicillin began to be mass produced, resistant strains Staphylococcus aureus were
isolated (35).
In the E. coli cells used in this study, the population was controlled, which
eliminated the possibility of acquiring antibiotic resistance genes from other organisms
and allowed the organisms to be tested for the hypothesis that mutations can result in
favorable genetic changes. This left random mutations to do the work of decreasing
sensitivity to the antibiotics. As can be seen from our experiment, some mutations will
render the bacteria more fit in this environment, but their ability to reproduce as quickly
as wild type cells was hampered (figures 2 and 3).
Further Experimentation
Further experimentation is being performed to determine whether or not the E.
coli cultures will continue to show decreased antibiotic sensitivity in successive
generations or whether they will ever gain complete resistance to these antibiotics, and
how long it takes if they do. Fitness tests should be performed in future experiments to
evaluate their overall fitness as compared to normal K12 cells. Further tests should be
done to determine whether the changes seen in the population of E. coli were due to
genetic mutations or were a result of adaptation, also known as phenotypic plasticity,
which is considered both non-genetic and reversible (33). The DNA from the adapted
strain could be compared to the DNA from the original E. coli K12 culture to see if any
genetic change, although unspecified as to effect, had occurred during the course of these
experiments.
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